• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,185.43 130.49
( 0.17%)
Global Indices
Nasdaq
52,540.76 21.12
(0.04%)
Dow Jones
7,564.35 28.01
(0.37%)
Hang Seng
68,716.36 972.86
(1.44%)
Nikkei 225
10,519.19 20.90
(0.20%)
Forex
USD-INR
95.76 0.51
(0.53%)
EUR-INR
109.18 0.48
(0.45%)
GBP-INR
128.06 0.48
(0.38%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
45.31
42658.02
EPS(TTM)
Face Value()
Div & Yield %
75.36
2
0.82
 

NIIT reports consolidated net loss of Rs 4.42 crore in the March 2026 quarter
May 14,2026
Net loss of NIIT reported to Rs 4.42 crore in the quarter ended March 2026 as against net profit of Rs 13.14 crore during the previous quarter ended March 2025. Sales rose 15.59% to Rs 99.74 crore in the quarter ended March 2026 as against Rs 86.29 crore during the previous quarter ended March 2025.

For the full year,net profit declined 88.55% to Rs 5.28 crore in the year ended March 2026 as against Rs 46.13 crore during the previous year ended March 2025. Sales rose 9.11% to Rs 390.17 crore in the year ended March 2026 as against Rs 357.58 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales99.7486.29 16 390.17357.58 9
OPM %-1.45-1.73 --3.420.91 -
PBDT6.7922.77 -70 52.1582.41 -37
PBT-0.6216.84 PL 23.1959.17 -61
NP-4.4213.14 PL 5.2846.13 -89